| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf8373f3013dca535a8f1ad5458725f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65e6910a938344ed08f0dba08cdf30a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efb6094265ae8d5656e94b8adb450d63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45ab00e7e6be7eeefb30ffac21b44b2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e77927c3cb3b6014a6c1159cb9d828d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2845 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 |
| filingDate |
2011-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79c4421861de4851446b32cdfd4b1f85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62373720a05917d44531b7f116916392
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32d9be663878cbc03ca8275a8827655e |
| publicationDate |
2014-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014147445-A1 |
| titleOfInvention |
Selective Targeting of the CD40L/Mac-1 Interaction by Small Peptide Inhibitors and its Use for the Treatment of Inflammation and Atherogenesis |
| abstract |
The CD40L/Mac-1 interaction is selectively targeted by small peptide inhibitors and/or antibodies and such peptides are used for the specific treatment of inflammation and atherogenesis. In particular, pharmaceutical compositions comprising a polypeptide having the amino acid sequence EQLKKSKTL and antibodies specifically binding to an epitope are disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109219447-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022147338-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019161550-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017205779-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10919967-B2 |
| priorityDate |
2010-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |